Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BIRC5 | O15392 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 2/20 | 0.38 |
| ▸ | CA9 | Q16790 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | BRD4 | O60885 | 1/20 | 0.38 |
| ▸ | BRPF1 | P55201 | 1/20 | 0.38 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.38 |
| ▸ | BRD9 | Q9H8M2 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.37 |
| ▸ | PRKCG | P05129 | 1/20 | 0.37 |
| ▸ | PRKCB | P05771 | 1/20 | 0.37 |
| ▸ | PRKCA | P17252 | 1/20 | 0.37 |
| ▸ | PRKACA | P17612 | 1/20 | 0.37 |
| ▸ | PRKACG | P22612 | 1/20 | 0.37 |
| ▸ | PRKACB | P22694 | 1/20 | 0.37 |
| ▸ | PRKCH | P24723 | 1/20 | 0.37 |
| ▸ | PRKCI | P41743 | 1/20 | 0.37 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.37 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19206978 | 0.74 | SMN1; SMN2 (0.53) | BIRC5CA12CA9MAPTBRD4 | |
| SCHEMBL29599202 | 0.66 | CDC7 (0.49) | BIRC5CA12CA9MAPTBRD4 | |
| SCHEMBL13052919 | 0.65 | BIRC5 (0.59) | BIRC5CA12CA9MAPTBRD4 | |
| SCHEMBL28617611 | 0.62 | CDC7 (0.53) | BIRC5CA12CA9MAPTBRD4 | |
| SCHEMBL13483670 | 0.62 | BIRC5 (0.50) | BIRC5CA12CA9MAPTBRD4 | |
| SCHEMBL11910172 | 0.62 | BIRC5 (0.60) | BIRC5CA12CA9MAPTBRD4 | |
| SCHEMBL29475118 | 0.61 | BIRC5 (0.70) | BIRC5CA12CA9MAPTBRD4 | |
| SCHEMBL170890 | 0.61 | BIRC5 (0.70) | BIRC5CA12CA9MAPTBRD4 | |
| SCHEMBL10153905 | 0.61 | BIRC5 (0.64) | BIRC5CA12CA9MAPTBRD4 | |
| SCHEMBL29388240 | 0.60 | RPS6KA5 (0.60) | BIRC5CA12CA9MAPTBRD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11716898-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-08-01 | — | — | US | disclosed |
| US-20200295276-A1 | Organic Electroluminescent Materials and Devices | UNIVERSAL DISPLAY CORP (US) | 2020-09-17 | — | — | US | disclosed |
| US-10707427-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2020-07-07 | — | — | US | disclosed |
| US-20170237018-A1 | Organic Electroluminescent Materials and Devices | UNIVERSAL DISPLAY CORPORATION | 2017-08-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170237018-A1 | Organic Electroluminescent Materials and Devices | OCIAD2, OCIAD1, JUND | BIRC5 1747/4885CA12 4584/4885CA9 4583/4885 |
| US-11716898-B2 | Organic electroluminescent materials and devices | OCIAD2, OCIAD1, JUND | BIRC5 1747/4885CA12 4584/4885CA9 4583/4885 |
| US-10707427-B2 | Organic electroluminescent materials and devices | OCIAD2, OCIAD1, JUND | BIRC5 671/4885CA12 4381/4885CA9 4131/4885 |
| US-20200295276-A1 | Organic Electroluminescent Materials and Devices | OCIAD2, OCIAD1, JUND | BIRC5 1747/4885CA12 4584/4885CA9 4583/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.